Fig. 5.

A, proteins with the gene ontology annotation proteolysis are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). B, proteins with the gene ontology annotation ribosomal are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). C, proteins PSMA1–7 and PSMB1–7 forming the 20 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). D, proteins PSME1–3 forming the 11 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). E, proteins PSMC1–6 and PSMD1–2 forming the base of the 19 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). F, proteins PSMD3–14 forming the lid of the 19 S proteasome are plotted by their cytoplasmic/nuclear ratios versus their cytoplasmic/nucleolar ratio as either mock-treated (blue) or etoposide-treated (red). G, proteins showing the highest relocalization to the nucleus after etoposide and proteins showing no relocalization to the nucleus are displayed with the log base 2 ratio of their enrichment in each compartment.